Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2025; 15(3): 143-149


Cassia alata butanol fraction anti-inflammatory effect on early expression of NFκB and cytokines in DENV-1 infected PBMCs

Aisya Alma Asmiranti Kartika, Beti Ernawati Dewi, Ibnu Agus Ariyanto, Tjahjani Mirawati Sudiro.




Abstract

Cytokine storms impact endothelial cells in vascular tissue, leading to plasma leakage during dengue infection. Several cytokines play important roles in dengue virus (DENV) infection such as TNF-α, IL-6, and IL-10. TNF-α and IL-6 were produced from the NFκB pathway. Prior investigation suggests the potential antiviral activity of butanol fraction derived from Cassia alata, but its potential as anti-inflammation remains unexplored. In this study, peripheral blood mononuclear cells from a healthy donor were infected with DENV-1 and treated with C. alata at 2 × IC50. mRNAs expression was measured by real-time PCR at two time points: 2 and 24 hours post-treatment. The results showed that the expression of NFκB remained relatively constant between 2 and 24 hours post-treatment, while TNF-α and IL-6 in the DENV-1-infected-group were elevated at 24 hours post-treatment. In contrast, IL-10 decreased at 24 hours post-treatment. At 2 hours after treatment, expression of NFκB, TNF-α, IL-6, and IL-10 decreased compared to the untreated group, by 0.084, 0.528, 3.519, and 0.445 fold, respectively. At 24 hours, NFκB expression was slightly down-regulated, while TNF-α, IL-6, and IL-10 were slightly up-regulated. The mRNA expression changes were not statistically significant, but the results showed that the effect of C. alata leaves butanol fraction was stronger at 2 hours post-treatment in the downregulation of TNF-α, IL-6, and IL-10 expression. Further study is needed to evaluate the potential and mechanism of C. alata as an anti-inflammation.

Key words: Cassia alata, butanol fraction, cytokines, NFκB, dengue virus






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.